News-Medical.Net on MSN

Scientists map step-by-step activation of brain receptors

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA ...
National Academies of Sciences%2c Engineering%2c and Medicine

Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders: A Workshop

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

GLP-1 receptor agonists improve glycemic and weight outcomes in children with type 2 diabetes, finds study

In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...
Medscape

Risk for Ischemic Optic Neuropathy From Glucagon-Like Peptide 1 Receptor Agonists Too Rare to be Detected

Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when appropriately prescribed ...
Monthly Prescribing Reference

Pemvidutide Gets Fast Track Status for Nonalcoholic Steatohepatitis

Pemvidutide is a novel, peptide-based glucagon-like peptide-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment ...

Research shows GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...